微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.25% | 218.64% | -68.22% | 54/68 | 2.31% | XD羚锐制 | 6.99% | 行业排名> |
| 2025-12-31 | 0.78% | -11.36% | -64.38% | 47/68 | 2.77% | XD羚锐制 | 22.39% | 行业排名> |
| 2025-09-30 | 2.19% | 12.31% | 397.73% | 46/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 0.44% | -31.25% | 465.55% | 51/68 | 3.21% | XD羚锐制 | 13.67% | 行业排名> |
| 2025-03-31 | 0.08% | -94.84% | -91.16% | 58/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 0.88% | 388.89% | -54.87% | 49/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 1.95% | 750% | 204.69% | 48/68 | 5.46% | XD羚锐制 | 20.44% | 行业排名> |
| 2024-06-30 | 0.64% | -37.86% | -57.53% | 53/68 | 2.54% | XD羚锐制 | 13.25% | 行业排名> |
| 2024-03-31 | 1.51% | 442.8% | 737.11% | 40/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 0.18% | -21.74% | 160% | 56/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | -0.3% | -115.71% | -129.13% | 62/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 1.03% | -14.88% | 271.04% | 57/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.28% | -50.32% | 20.7% | 60/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 0.23% | -89.15% | -87.96% | 55/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 1.91% | 42.54% | 57.85% | 58/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 1.21% | 47.56% | 116.54% | 56/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.56% | 27.7% | -73.64% | 55/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 2.12% | 40.4% | 58.21% | 55/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 1.34% | -33.5% | 63.41% | 59/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 0.82% | 74.36% | 87.39% | 60/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.44% | 818.56% | -71.02% | 60/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 1.51% | 96.1% | -25.07% | 56/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 2.02% | -10.4% | 328.47% | 59/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 0.47% | -58.12% | 872.25% | 58/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | -0.06% | -109.78% | -107.91% | 60/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 0.77% | -67.51% | -65.76% | 55/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 2.25% | 0.15% | 100.29% | 56/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 1.12% | -21.01% | 80.33% | 58/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 0.62% | 41.52% | -73.73% | 59/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 2.37% | -23.05% | 5.53% | 55/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 2.25% | -15.89% | 57.99% | 56/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 1.42% | 5.27% | 223.07% | 56/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 0.44% | 51.72% | -85.71% | 59/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 3.08% | 32.76% | 15.36% | 56/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 2.67% | 10.79% | 97.72% | 56/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 1.35% | 8.9% | 365.66% | 58/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 0.29% | 0% | -87.5% | 56/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 2.32% | 25.41% | -3.73% | 58/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 2.41% | 13.09% | 94.35% | 51/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 1.24% | 29.26% | 327.59% | 57/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 0.29% | 24.04% | -84.32% | 53/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |